• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX CUSTOM PACK; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX CUSTOM PACK; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Catalog Number CX-XRX00660
Device Problem Infusion or Flow Problem (2964)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/19/2020
Event Type  Injury  
Manufacturer Narrative
Udi not required for product code.Implanted date: device was not implanted.Explanted date: device was not explanted.Occupation: clinical engineer.Pma/510(k): k130520.The actual sample was received for evaluation.Visual inspection revealed no break, or no other obvious anomaly that could lead to the reported poor gas transfer performance.The gas channel was blown with air.As a result, liquid was flown out from the gas outlet port side.The liquid was tested with protein test paper ("uriace"), and the presence of protein was confirmed.From this, it is likely that the plasma leak occurred due to hydro-philization of the fiber, however, it was not determined when (during use or during return shipment to the factory) the hydro-philization of the fiber occurred.The actual sample, after having been rinsed and dried, was tested for its gas transfer performance in accordance with the factory's inspection protocol.As a result, no anomalies were revealed in the gas transfer performance of the actual sample, with the obtained values meeting the factory specifications.Blood conditions: hb:12g/dl, temp.: 37°c., ph:7.4, svo2:65%, pvco2: 45mmhg.Circulation conditions: blood flow rate: 6l/min and 4l/min, v/q=1, fio2=100%.O2 transfer volume: @6l/min= 379 ml/min.@4l/min= 272 ml/min.Co2 removal volume: @6l/min= 299 ml/min.@4l/min= 221 ml/min.A review of the device history record and product-release judgement record of the involved product code/lot# combination was conducted with no findings.The pump record involved in this complaint was not available for review.Ifu states: measure blood gases and make necessary adjustments as follows.A.Control pao2 by changing concentration of oxygen in ventilating gas using gas blender.To decrease paco2, increase total gas flow.To increase paco2, decrease total gas flow.B.Control paco2 by changing the total gas flow.To decrease paco2, increase total gas flow.To increase paco2, decrease total gas flow.Based on the provided information and investigation results, there is no definitive evidence that this event was related to a device defect or malfunction.It is likely that co2 could not be sufficiently removed due to the circulation condition (blood temperature, v/q ratio, etc.), or it is possible that the pco2 in the suctioned blood or in the blood flowing into the oxygenator had been increased due to the co2 gas blown in the surgical field.From the state of the actual sample, however, the definite cause of the poor gas transfer performance could not be determined.The exact cause of the reported event cannot be definitively determined based on the available information.(b)(4).
 
Event Description
The user facility reported that the involved capiox custom pack was used during the a taa case.After five hours of circulation and de-clamping, co2 removal performance dropped.Gas flow at 10l/min using gas blender could not decrease co2 to less than 80.Another oxygenator was added.Reported no problem with o2 value.The procedure outcome was not reported.The patient was not harmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX CUSTOM PACK
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, 418
JA  418
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, 418
JA   418
Manufacturer Contact
theresa mussaw
reg. no. 2243441
265 davidson ave suite 320
somerset, NJ 08873
8002837866
MDR Report Key10821696
MDR Text Key217656272
Report Number9681834-2020-00229
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K071494
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 11/11/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/30/2021
Device Catalogue NumberCX-XRX00660
Device Lot Number200617
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/22/2020
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/19/2020
Initial Date FDA Received11/11/2020
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/17/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-